An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease

Published:2022-03 Issue: Volume:28 Page:71-77
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Srivastava Shashikant^ORCID,Pasipanodya Jotam G.,Heysell Scott K.,Boorgula Gunavanthi D.,Gumbo Tawanda,McShane Pamela J.,Philley Julie V.

Funder

The University of Texas at Tyler

NIAID

American Thoracic Society

NICHD

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference28 articles.

1. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008–2015;Winthrop;Ann Am Thorac Soc,2020

2. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline;Daley;Clin Infect Dis,2020

3. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases;Griffith;Am J Respir Crit Care Med,2007

4. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis;Dorman;N Engl J Med,2021

5. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria;van Ingen;Drug Resist Updat,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2023-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP